|
102
|
331
|
5piwA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 45) |
|
105
|
331
|
5pkgA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 101) |
|
105
|
331
|
5plqA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 147) |
|
106
|
331
|
5pigA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 29) |
|
102
|
331
|
5pl1A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 122) |
|
104
|
331
|
5pl9A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 130) |
|
104
|
331
|
5pjbA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 60) |
|
103
|
331
|
5pnhA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 211) |
|
104
|
331
|
5pk9A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 94) |
|
105
|
331
|
5pllA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 142) |
|
104
|
331
|
5pluA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 151) |
|
102
|
322
|
5phdA |
Pandda analysis group deposition -- crystal structure of jmjd2d in complex with n09419a |
|
102
|
331
|
5pjyA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 83) |
|
106
|
331
|
5pkvA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 116) |
|
105
|
331
|
5pi3A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 16) |
|
103
|
331
|
5pjjA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 68) |
|
103
|
331
|
5pkxA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 118) |
|
105
|
331
|
5plsA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 149) |
|
106
|
331
|
5piaA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 23) |
|
102
|
331
|
5pkoA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 109) |
|
104
|
331
|
5pldA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 134) |
|
103
|
331
|
5pm2A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 160) |
|
104
|
331
|
5ph3A |
Pandda analysis group deposition -- crystal structure of jmjd2d in complex with n09575a |
|
105
|
331
|
5pi2A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 15) |
|
104
|
331
|
5pkeA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 99) |
|
103
|
331
|
5pmaA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 168) |
|
105
|
331
|
5pi7A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 20) |
|
105
|
331
|
5pnqA |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 220) |
|
104
|
331
|
5pj8A |
Pandda analysis group deposition -- crystal structure of jmjd2d after initial refinement with no ligand modelled (structure 57) |
|
108
|
351
|
5a80A |
Crystal structure of human jmjd2a in complex with compound 40 |
|
112
|
351
|
5a7oA |
Crystal structure of human jmjd2a in complex with compound 42 |
|
101
|
346
|
5a7wB |
Crystal structure of human jmjd2a in complex with compound 35 |
|
109
|
351
|
5a7qA |
Crystal structure of human jmjd2a in complex with compound 30 |
|
96
|
345
|
5a7wA |
Crystal structure of human jmjd2a in complex with compound 35 |
|
111
|
350
|
5a7pA |
Crystal structure of human jmjd2a in complex with compound 36 |
|
110
|
351
|
5a7nA |
Crystal structure of human jmjd2a in complex with compound 43 |
|
110
|
345
|
5a7sA |
Crystal structure of human jmjd2a in complex with compound 44 |
|
103
|
348
|
5ly2A |
Jmjd2a/ kdm4a complexed with ni(ii), nog and macrocyclic peptide inhibitor cp2_r6kme3 (13-mer) |
|
80
|
318
|
5iwfA |
Linked kdm5a jmj domain bound to the inhibitor 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinamid |
|
91
|
317
|
5iw0A |
Linked kdm5a jmj domain bound to the inhibitor n19 [2-(5-((4-chloro-2-methylbenzyl)oxy)-1h-pyrazol-1-yl)isonicotinic acid] |
|
136
|
774
|
5k4lA |
Crystal structure of kdm5a in complex with a naphthyridone inhibitor |
|
91
|
317
|
5ivyA |
Linked kdm5a jmj domain bound to the inhibitor n16 [3-(2-(4-chlorophenyl)acetamido)isonicotinic acid] |
|
151
|
462
|
5a3wA |
Crystal structure of human plu-1 (jarid1b) in complex with pyridine-2, 6-dicarboxylic acid (pdca) |
|
138
|
462
|
5fzbA |
Crystal structure of the catalytic domain of human jarid1b in complex with maybridge fragment 4-pyridylthiourea (n06275b) (ligand modelled based on pandda event map, sgc - diamond i04-1 fragment screening) |
|
140
|
462
|
5fzkA |
Crystal structure of the catalytic domain of human jarid1b in complex with 3d fragment n,3-dimethyl-n-(pyridin-3-ylmethyl)-1,2-oxazole-5- carboxamide (n10051a) (ligand modelled based on pandda event map, sgc - diamond i04-1 fragment screening) |
|
143
|
462
|
5fyzA |
Crystal structure of the catalytic domain of human jarid1b in complex with 3d fragment 2-(2-oxo-2,3-dihydro-1h-indol-3-yl)acetonitrile (n10063a) |
|
140
|
462
|
5fysA |
Crystal structure of the catalytic domain of human jarid1b in complex with d-2-hydroxyglutarate |
|
102
|
330
|
5fpbA |
Crystal structure of human kdm4d in complex with 2-1h-pyrazol-4-yloxy- 3h,4h-pyrido-3,4-d-pyrimidin-4-one |
|
138
|
462
|
5fz3A |
Crystal structure of the catalytic domain of human jarid1b in complex with maybridge fragment 3,6-dihydroxybenzonorbornane (n08776b) (ligand modelled based on pandda event map) |
|
145
|
462
|
5fzdA |
Crystal structure of the catalytic domain of human jarid1b in complex with l-2-hydroxyglutarate |
